ArticleJournal for immunotherapy of cancer2021

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.

Haiying Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.